Vestipitant 28-day Tolerance Study

Clinical trial NCT00992160 · COMPLETED

Trial details

NCT number: NCT00992160
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Sleep Disorders

Start date: 2009-05-01
Primary completion: 2009-09-01
Enrollment: 161

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.